|
|
|
40
|
0813C
|
EPHEDRINE HCL 50MG/ML INJ (VEV/AHI)
|
EPHEDRINE HYDROCHLORIDE
|
EPHEDRINE HCL
|
10X1ML
|
B
|
268.43
|
26.84
|
INJECTION
|
0
|
VIAL
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
|
42
|
1332L
|
VERFEN 50MCG/ML INJ (VEV) FENTANYL
|
FENTANYL CITRATE
|
VERFEN
|
5X10ML
|
BQ
|
23.65
|
4.73
|
AMPG
|
0
|
BOX
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
1383D
|
VERMOR SR 30MG TAB (VEV/AHI) MORPHINE SULPHATE SR
|
MORPHINE SULPHATE SR
|
VERMOR SR
|
10X10
|
A
|
64.70
|
0.65
|
TABLET
|
30
|
TAB
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
2
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
41
|
1383D
|
VERMOR 30MG SR TAB (VEV) MORPHINE SULPHATE
|
MORPHINE SULPHATE
|
VERMOR
|
10X10
|
A
|
392.93
|
3.9293
|
TABSR
|
30
|
BOX
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
2
|
OPIATE AGONISTS
|
|
|
|
|
42
|
1383D
|
VERMOR 30MG SR TAB (VEV) MORPHINE SR
|
MORPHINE SR
|
VERMOR
|
10X10
|
B
|
404.16
|
4.04
|
TAB
|
0
|
BLIS
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
ORAL
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
13855
|
VERMOR IR 10MG TAB (VEV/AHI) MORPHINE SULPHAT
|
MORPHINE SULPHATE
|
VERMOR IR
|
10X10
|
A
|
49.56
|
0.50
|
TABLET
|
112
|
TAB
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
2
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|
|
|
|
42
|
13855
|
VERMOR IR 10MG TAB (VEV) MORPHINE SULPHA
|
MORPHINE SULPHATE
|
VERMOR IR
|
10X10
|
B
|
178.02
|
1.78
|
TAB
|
112
|
BLIS
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
ORAL
|
2
|
OPIATE AGONISTS
|
|
|
|
|
42
|
15055
|
PHENOBARBITONE 200MG/ML INJ (VEV)
|
PHENOBARBITONE
|
PHENOBARBITONE
|
10X1ML
|
BQ
|
32.29
|
3.23
|
AMPG
|
0
|
BOX
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
281204
|
BARBITURATES (ANTICONVULSANTS)
|
2026-04-01
|
|
|
IV
|
0
|
BARBITURATES (ANTICONVULSANTS)
|
|
|
|
|
41
|
1605B
|
VERZEPAM 5MG/ML IV/IM INJ (VEV) DIAZEPAM (B)
|
DIAZEPAM
|
VERZEPAM
|
10X2ML
|
B
|
29.36
|
2.9358
|
AMP
|
60
|
BOX
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
282408
|
BENZODIAZEPINES (SEDATIVES)
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
BENZODIAZEPINES (SEDATIVES)
|
|
|
|
|
41
|
1612X
|
DOCETAXEL 80MG INJ (VEN)
|
DOCETAXEL
|
DOCETAXEL
|
4ML VIAL
|
BQ
|
38.4643
|
38.4643
|
VIAL
|
0
|
VIAL
|
VEN
|
VENUS REMEDIES LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
3681Q
|
N-XONE 0.4MG/ML INJ (VEV) NALOXONE (B)
|
NALOXONE
|
N-XONE
|
10X1ML
|
B
|
47.3
|
4.7299
|
AMP
|
0
|
BOX
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2810
|
OPIATE ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE ANTAGONISTS
|
|
|
|
|
41
|
71124
|
CISPLATIN 1MG/ML INJ (VEN) (BQ)
|
CISPLATIN
|
CISPLATIN
|
100ML
|
BQ
|
29.19
|
29.1948
|
VIAL
|
0
|
VIAL
|
VEN
|
VENUS REMEDIES LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|